How a VC Sees the Current Medtech Landscape
By being in a position to see hundreds of pitches a year, VCs benefit from the opportunity to formulate a unique view of the needs, opportunities, trends, and emerging technologies in a market. Want to get a VC’s perspective on the current state of the medtech landscape and how he anticipates making investment decisions in this environment? Join the Rosenman Institute on March 26 to hear from Kevin Chu of F-Prime Capital.